Cannabinoid Receptor-1 is a Major Focus of Drug Developers in the Fibromyalgia Competitive Landscape, 2021 Market Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Fibromyalgia – Competitive Landscape in 2021” report has been added to ResearchAndMarkets.com’s offering.

This reports provides a data-driven overview of the current and future competitive landscape in fibromyalgia therapeutics.

In fibromyalgia Cannabinoid receptor-1 is a major focus of drug developers. There are 24 drugs in the pipeline with 94% molecules present in early stage. Mid-sized Pharma dominates R&D in this indication.

The increasing prevalence and preference for newer reformulated therapies will drive the market’s growth, but wide availability of low cost generic products is expected to limit the uptake of branded therapies.

Fibromyalgia – Competitive Landscape in 2021 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Scope

• Disease epidemiology
• Marketed drugs assessment
• Pipeline drugs assessment
• Clinical trials assessment
• Commercial assessment
• Social media overview
• Digital marketing overview

Key Topics Covered:

1 Preface

1.1 Table of Contents

1.2 Abbreviations

1.3 Related Reports

1.4 Upcoming Related Reports

2 Executive Summary

2.1 Key Findings

2.2 Key Events

3 Introduction

3.1 Report Scope

3.2 Disease Overview Epidemiology Overview

3.3 Epidemiology

4 Marketed Drugs Assessment

4.1 Marketed Drugs Overview

4.2 Marketed Drug Profiles

5 Pipeline Assessment

5.1 Pipeline Overview

5.2 Pipeline Breakdown by Region

5.3 Pipeline Breakdown by Molecule Type and Target

5.4 Drug Review Designations

5.5 Phase Transition Success Rates

5.6 Likelihood of Approval

6 Clinical Trial Assessment

6.1 Clinical Trials Overview by Phase

6.2 Overview by Region

6.4 Therapy Area Perspective

6.4 Leading Sponsors

6.5 Enrollment Analytics

6.6 Feasibility Analysis

7 Commercial Assessment

7.1 Upcoming Market Catalysts

8 Social Media and Digital Marketing

8.1 Key Twitter Chatter

8.2 Top Branded Websites

8.3 Trust Flow and Citation Flow

9 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/i6rwu3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900